Impact of Immune Cell Types on Endometrial Cancer Survival
Author Information
Author(s): Hattori Satomi, Yoshikawa Nobuhisa, Liu Wenting, Matsukawa Tetsuya, Kubokawa Mei, Yoshida Kosuke, Yoshihara Masato, Tamauchi Satoshi, Ikeda Yoshiki, Yokoi Akira, Shimizu Yusuke, Niimi Kaoru, Kajiyama Hiroaki
Primary Institution: Nagoya University
Hypothesis
Each molecular subtype of endometrial cancer may be associated with a distinct immunophenotype that influences patient prognosis.
Conclusion
Evaluating both molecular classification and immunophenotype can enhance personalized immunotherapy strategies for endometrial cancer patients.
Supporting Evidence
- Three distinct immunophenotypes were identified based on CD8-positive TIL patterns.
- The inflamed phenotype was associated with better prognosis compared to the non-inflamed phenotypes.
- RNA-seq analysis revealed specific gene expressions linked to immunophenotypes.
- Patients with the excluded or desert phenotypes had poorer survival rates.
- Integration of immunophenotypes with molecular classification enhances prognostic accuracy.
Takeaway
This study found that different types of immune cells in endometrial cancer can affect how well patients do, and understanding this can help doctors choose better treatments.
Methodology
The study analyzed two cohorts of endometrial cancer patients, examining CD8-positive tumor-infiltrating lymphocytes and correlating them with molecular subtypes and survival outcomes.
Potential Biases
Potential bias due to the limited sample size and retrospective analysis of one cohort.
Limitations
The study only assessed CD8+ TILs and did not explore other immune cell types or the interaction of immune cells.
Participant Demographics
Median age of participants was 58 years, with a range from 32 to 84 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website